{"id":"NCT01336608","sponsor":"GlaxoSmithKline","briefTitle":"A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD","officialTitle":"A 24-week Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder Delivered Once-daily Via a Novel Dry Powder Inhaler on Arterial Stiffness Compared With Placebo and Vilanterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03-04","primaryCompletion":"2014-11-04","completion":"2014-11-04","firstPosted":"2011-04-18","resultsPosted":"2015-07-10","lastUpdate":"2017-11-08"},"enrollment":446,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Fluticasone Furoate/Vilanterol","otherNames":[]},{"type":"DRUG","name":"Vilanterol","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Fluticasone Furoate/Vilanterol","type":"EXPERIMENTAL"},{"label":"vilanterol","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to investigate the effect of fluticasone furoate/vilanterol Inhalation Powder on arterial stiffness compared with placebo and vilanterol over a 24-week treatment period in subjects with COPD and aortic pulse wave velocity of 11.0 m/s or above.","primaryOutcome":{"measure":"Mean Change From Baseline (BL) in Aortic Pulse Wave Velocity (aPWV) at the End of the 24-week Treatment Period (Day 168)","timeFrame":"BL to Day 168","effectByArm":[{"arm":"Placebo QD","deltaMin":-1.97,"sd":0.279},{"arm":"VI 25 µg QD","deltaMin":-1.95,"sd":0.241},{"arm":"FF/VI 100/25 µg QD","deltaMin":-1.75,"sd":0.256}],"pValues":[{"comp":"OG000 vs OG001","p":"0.969"},{"comp":"OG000 vs OG002","p":"0.568"},{"comp":"OG001 vs OG002","p":"0.566"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":26},"locations":{"siteCount":72,"countries":["United States","Germany","Norway","Philippines","South Korea","Thailand"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":145},"commonTop":["Nasopharyngitis","Headache","Back pain","Oral candidiasis","Upper respiratory tract infection"]}}